Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 62636

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
April 16, 2012
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Bracco Diagnostics Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15

D-1663-2012
Recall number
D-1663-2012
Initiated
April 16, 2012
Classification
Class III
Status
Terminated
Recalling firm
Bracco Diagnostics Inc
Quantity
47,750 vials

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Short Fill: The product is being recalled due to a potential underfill of the affected vials.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Short Fill: The product is being recalled due to a potential underfill of the affected vials.

Code information

Lot S1P272A Expiry Date: December 2014

Distribution pattern

Nationwide